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Aims We investigated whether routine T-stenting reduces restenosis of the side branch as compared with provisional T-
stenting in patients with de novo coronary bifurcation lesions.
Methods
and results
Our randomized study assigned 101 patients with a coronary bifurcation lesion to routine T-stenting with sirolimus-
eluting stents (SES) in both branches and 101 patients to provisional T-stenting with SES placement in the main
branch followed by kissing-balloon angioplasty and provisional SES placement in the side branch only for inadequate
results. Primary endpoint was per cent diameter stenosis of the side branch at 9 month angiographic follow-up.
Angiographic follow-up in 192 (95%) patients revealed a per cent stenosis of the side branch of 23.0+20.2%
after provisional T-stenting (19% with side-branch stent) and of 27.7+24.8% (P ¼ 0.15) after routine T-stenting
(98.2% with side-branch stent). The corresponding binary restenosis rates were 9.4 and 12.5% (P ¼ 0.32), prompting
re-intervention in 5.0 and 7.9% (P ¼ 0.39), respectively. In the main branch, binary restenosis rates were 7.3% after
provisional and 3.1% after routine T-stenting (P ¼ 0.17). The overall 1 year incidence of target lesion re-intervention
was 10.9% after provisional and 8.9% after routine T-stenting (P ¼ 0.64).
Conclusions Routine T-stenting with SES did not improve the angiographic outcome of percutaneous coronary intervention of
coronary bifurcation lesions as compared with stenting of the main branch followed by kissing-balloon angioplasty
and provisional side-branch stenting.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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Introduction
Theoptimaltechnicalapproachtocatheter-basedtreatmentofcor-
onary bifurcation lesions is still a matter of debate. Compared with
plainballoonangioplasty,stentsimprovedtheprimaryresultofcath-
eter treatment of bifurcation lesions and reduced the risk of abrupt
closure.
1–4Nevertheless, in the era of bare-metal stents, the need
for re-intervention continued to be high.
2–4 Speciﬁcally, recur-
rences in the side branch constituted a major problem. Although
the analysis of registry data revealed better outcome, if stent place-
ment in the side branch could be avoided, restenosis rates in non-
stented side branches were still in the range of 30%.
2–4
Drug-eluting stents held promise to solve this issue. The ﬁrst
randomized study on drug-eluting stents for bifurcation lesions
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doi:10.1093/eurheartj/ehn455revealed restenosis rates as low as 4% in the main branch.
5 In the
side branch, however, the results were disappointing with resteno-
sis rates of 20%, irrespective of whether the operators intended to
avoid the side-branch stent or pursued routine side-branch stent-
ing.
5 In addition, the incidence of 6.3% for stent thrombosis among
patients with a side-branch stent was worrisome.
5 The authors
highlighted the problem that conventional T-stenting results in
incomplete coverage of the origin of the side branch. They
suggested that this may impair outcome.
5 Interpretation of their
study was, however, hampered by a large number of patients
with side-branch stents in the provisional side-branch stenting
arm and by the diversity of techniques for stenting of the side
branch.
We hypothesized that stenting of the side branch with
sirolimus-eluting stents (SES) can reduce side-branch restenosis,
if a stenting technique is applied that avoids non-stented gaps at
the oriﬁce of the side branch with minimal stent distortion. To
test this hypothesis we performed the ‘Bifurcations Bad Krozingen’
(BBK) study to assess the effect of routine T-stenting on restenosis
of the side branch as compared with provisional T-stenting.
Methods
Study population
The study included patients with stable angina pectoris or a positive
stress test, attributable to a de novo bifurcation lesion of a native cor-
onary artery with .50% diameter stenosis of the main branch or the
side branch, as deﬁned by Lefevre et al.
6 Patients were not eligible, if on
visual estimation the vessel size of the side branch was ,2.25 mm or if
the main branch was .4 mm in diameter or ,2.5 mm. Other major
exclusion criteria were left main stenosis, intraluminal thrombus,
heavy calciﬁcation, severe tortuosity, contraindication to aspirin,
heparin, clopidogrel, stainless steel, or sirolimus, and a history of bleed-
ing diathesis or coagulopathy. The study, carried out according to the
Declaration of Helsinki, was approved by the ethics committee of the
medical faculty of the University of Freiburg, Germany. All patients
gave written informed consent before enrolment.
Randomization, stenting procedure,
and follow-up
The study was designed as a non-blinded, randomized, single-centre
trial. We allocated patients to provisional or routine T-stenting using
a computer-generated random sequence, set in blocks of 20. The
size of the block and the random sequence were selected by the stat-
istician and were unknown to the investigators and medical staff caring
for the patients. Randomization was performed immediately before
catheter treatment of the bifurcation.
At least 2 h before the intervention, all patients received a loading
dose of 600 mg of clopidogrel. In the catheterization laboratory, we
administered an intra-arterial dose of 100–140 U/kg heparin plus i.v.
aspirin, 500 mg, if the patient was not on chronic treatment with
aspirin. We did not administer glycoprotein IIb/IIIa inhibitors, except
for bail out. For the stenting procedure, we exclusively used SES
(CypherTM, Cordis Corporation).
After placement of the stent in the main branch, rewiring and pre-
dilatation of the side branch, we advanced the second stent in the
side branch and placed a balloon in the main branch at the oriﬁce of
the side branch. Then, the stent in the side branch was meticulously
positioned, taking care that the marker band and about the ﬁrst half
millimetre of the stent were within the main branch stent. When the
optimal position of the side-branch stent was achieved, we deployed
the side-branch stent by a kissing balloon manoeuvre, ﬁrst inﬂating the
side-branch balloon with the stent and immediately afterwards the
main branch balloon. Among the many approaches to bifurcation
stenting, we speciﬁcally chose our technique with the intention to
avoid non-stented gaps at the oriﬁce of the side branch with
minimal stent distortion or stent overlap in the carina region. In the
provisional T-stenting group, the main branch was stented and ﬁnal
kissing-balloon dilatation with a balloon matching the size of the
vessel was performed in all patients, even if there was no relevant
side-branch stenosis. This was done to adapt the main branch stent
to the oriﬁce of the side branch and to facilitate access to the side
branch, in case it will be needed in the future. Thus, ﬁnal ‘kissing-
balloon’ dilatation was performed in both groups irrespective of
whether they were assigned to routine or provisional T-stenting. In
the provisional T-stent arm, crossover to side-branch stenting was
mandated in case of a ﬂow limiting dissection or residual stenosis of
 75%. After percutaneous coronary intervention, we recommended
lifelong aspirin ( 100 mg/day) and clopidogrel ( 75 mg/day) for 6
months.
Plasma concentrations of creatine kinase and its MB isoenzyme were
systematically determined for 48 h after the intervention. In addition,
we obtained at least three ECG recordings during that time. Patients
returned to the hospital for routine angiographic re-study and clinical
evaluation at 9 months. We also conducted an interview at 30 days, at
1 year, and at 2 years. For patients reporting cardiac symptoms, at least
one clinical and electrocardiographic examination was performed in
the outpatient clinic or by the referring physician. At 1 year and at 2
years, all information derived from contingent hospital re-admission
records or provided by the referring physician or by the outpatient
clinic were entered into the computer database.
Quantitative coronary angiography
By visual assessment, bifurcation lesions were characterized according
to the Medina classiﬁcation.
7 For quantitative coronary angiography,
angiograms obtained at baseline, at completion of the intervention,
and at 9 month follow-up were analysed with the use of a computer-
based system dedicated to bifurcation analysis (Qangio XA, version
7.0, Medis, Leiden, Netherlands), according to the standard operating
procedure of our angiographic core laboratory.
8 We obtained quanti-
tative angiographic measurements of the three segments of the bifur-
cation lesion: the proximal and distal segment of the main branch and
the side branch. We always performed measurements in the stented
or balloon-treated portion of the vessel (in-stent) and in the distal
or proximal 5 mm margin (edge). In-segment analyses comprised the
in-stent and the edge area. In addition, we obtained the bifurcation
angle from the analysis system.
Study endpoints and deﬁnitions
Primary endpoint of the study was the in-segment per cent diameter
stenosis of the side branch at 9 month follow-up. In addition, we
assessed various other variables of 9 month angiographic outcome,
both in the side branch and in the main branch.
We also assessed 1 and 2 year clinical outcome. We monitored the
incidences of death from any cause and myocardial infarction. Myocar-
dial infarction was deﬁned as the presence of new Q waves in two or
more contiguous electrocardiographic leads or an elevation of creatine
kinase or its MB isoenzyme to at least three times the upper limit of
normal in two samples during hospitalization. After discharge, the diag-
nosis of myocardial infarction was made according to the European
M. Ferenc et al. 2860Society of Cardiology/American College of Cardiology consensus
document and based on new rise in troponin T  0.03 mg/L associated
with either typical symptoms and/or typical ECG changes and/or
typical angiographic ﬁndings.
9 We determined the incidence of stent
thrombosis according to the Academic Research Consortium (ARC)
criteria.
10 In addition, we assessed target lesion revascularization
(TLR) deﬁned as coronary artery bypass surgery or repeat percuta-
neous angioplasty involving the stented segment and performed for
symptoms or signs of ischaemia in the presence of angiographic rest-
enosis. All events were classiﬁed and adjudicated by two physicians
not involved in the follow-up process. Clinical data entry and quantitat-
ive coronary angiography were double-checked by a trained study
personnel.
Statistical methods
On the basis of previously published data,
5 we assumed a per cent
diameter stenosis of 32+22% in the side branch after provisional T-
stenting. To achieve 80% power, to detect a 33% reduction in per cent
diameter stenosis of the side branch by routine T-stenting as com-
pared with provisional T-stenting at a level of signiﬁcance of 5%, we
needed a sample size of 160 patients. To allow for potential losses
to angiographic follow-up, we aimed for 200 patients. All analyses
were performed according to the ‘intention to treat’ principle.
Hence, patients in the provisional T-stenting arm who received a side-
branch stent and patients in the routine T-stenting arm in whom the
side-branch stent could not be placed were analysed as randomized
and not according to the treatment they were actually given. The
analysis of angiographic outcome measures, including the primary end-
point, was restricted to patients with follow-up angiography, whereas
the analysis of clinical outcome was based on all patients as
randomized.
For all statistical analyses, we used the SPSS software package
(version 15, SPSS Inc., Chicago, IL, USA). Discrete variables are
reported as counts (percentages), and continuous variables are
reported as mean+standard deviation. For discrete variables, we
tested differences between groups with the x
2 test or Fisher’s exact
test when expected cell sizes were ,5. We used the two-tailed
t-test to compare continuous variables. Where appropriate, we also
performed ANCOVA with the baseline measurement as covariate,
to corroborate our primary analysis. ANCOVA always conﬁrmed
the result of the t-test. All tests were two-sided and statistical signiﬁ-
cance was set at 5%.
Results
Study cohort and procedural outcome
The trial proﬁle is shown in Figure 1. From April 2005 to August
2006, we enrolled 202 consecutive patients; 101 were assigned
to the provisional T-stenting and 101 to routine T-stenting.
Figure 1 Flow diagram of the Bad Krozingen Bifurcation Study. QCA, quantitative coronary angiography.
Routine vs. provisional T-stenting 2861We obtained 9 month angiographic follow-up in 192 patients
(96 patients of each group); reasons for missing follow-up angio-
graphy were death in three patients and patient refusal in seven.
Two-year clinical follow-up was complete in all surviving patients.
With respect to baseline demographic and clinical character-
istics (Table 1), there were no signiﬁcant differences between the
two study groups. The mean age of our study population was 67
years, and 79% were male. Diabetes mellitus was prevalent in
22%. The two groups were well balanced with respect to angio-
graphic characteristics, including the distribution of the Medina
classiﬁcation (Table 2). In both groups, 68% of the bifurcation
lesions involved both the side branch and the main branch, and
the majority was located in the territory of the left anterior des-
cending coronary artery. On average, vessel sizes were 3.1 mm
in the proximal main branch and 2.4 mm in the side branch with
lesion lengths of 21 and 10 mm, respectively. The mean angle
between side branch and main branch was 498.
In 19 patients assigned to provisional T-stenting, a stent was
placed in the side branch because of a relevant residual stenosis
after the kissing-balloon manoeuvre in 14 patients and because
of a ﬂow-limiting dissection in ﬁve patients. In three patients
assigned to routine T-stenting, the main-branch stent could
not be crossed with the side-branch stent, despite multiple
kissing-balloon pre-dilatations. Two patients received abciximab
periinterventionally.
Angiographic results
We did not ﬁnd any signiﬁcant differences between the two study
groups in any of the angiographic variables for restenosis assessed
at 9 month follow-up (Table 3). As shown in Figure 2, the cumulat-
ive distribution of in-segment per cent diameter stenosis of the
side branch at angiographic follow-up, our primary study endpoint,
did not differ signiﬁcantly between the two study groups (P ¼
0.15). On average, it was of 23.0+20.2% after provisional
T-stenting and 27.7+24.8% after routine T-stenting [mean differ-
ence 4.7; 95% conﬁdence interval (CI) 211.1 to 1.7]. The
corresponding binary restenosis rates were 9.4 and 12.5%, respect-
ively [relative risk (RR) 0.75; 95% CI 0.32–1.78; P ¼ 0.32]. As there
was no detectable late loss in the edge in either group (Table 3),
the ﬁndings on in-stent per cent diameter stenosis were similar
to those on in-segment per cent diameter stenosis (Figure 2).
................................................................................
Table 1 Baseline clinical characteristics
Provisional
T-stenting
(n 5 101)
Routine
T-stenting
(n 5 101)
P-value
Age (years) 66.7+9.2 66.9+10.5 0.92
Male (%) 80 (79.4) 79 (78.2) 0.50
Diabetes mellitus (%) 26 (25.7) 19 (18.8) 0.16
Current smoker (%) 10 (9.9) 14 (13.9) 0.26
LDL-cholesterol (mg/dL) 130+44 126+40 0.52
Hypertension (%) 93 (92.1) 90 (89.1) 0.32
Renal dysfunction (%) 21 (20.8) 24 (23.7) 0.61
Previous MI (%) 19 (18.8) 21 (20.8) 0.43
History of PCI (%) 45 (44.6) 52 (51.5) 0.20
History of CABG (%) 4 (4.0) 3 (3.0) 0.50
Ejection fraction (%) 59+12 61+12 0.30
CABG, coronary artery bypass grafting; LDL, low-density lipoprotein; MI,
myocardial infarction; PCI, percutaneous coronary intervention.
................................................................................
................................................................................
................................................................................
................................................................................
................................................................................
................................................................................
................................................................................
................................................................................
................................................................................
Table 2 Baseline angiographic and procedural
characteristics
Provisional
T-stenting
(n 5 101)
Routine
T-stenting
(n 5 101)
P-value
Number of vessels affected (%)
One vessel 35 (34.7) 26 (25.8) 0.45
Two vessels 28 (27.7) 27 (26.7)
Three vessels 38 (37.6) 48 (47.5)
Location of bifurcation (%)
LAD territory 76 (75.2) 74 (73.3) 0.52
LCX territory 16 (15.8) 21 (20.8)
RCA territory 9 (8.9) 6 (5.9)
Medina classiﬁcation (%)
111 36 (35.6) 31 (30.7) 0.91
110 12 (11.9) 10 (9.9)
101 8 (7.9) 6 (5.9)
100 3 (3.0) 2 (2.0)
011 25 (24.8) 32 (31.7)
010 12 (11.9) 14 (13.9)
001 5 (5.0) 6 (5.9)
Vessel size (mm)
Main branch 3.08+0.40 3.08+0.38 0.10
Side branch 2.39+0.31 2.38+0.37 0.87
Lesion length (mm)
Main branch 21.7+7.5 20.9+8.2 0.48
Side branch 10.4+4.1 9.9+4.2 0.36
Bifurcation angle (8) 49.9+59.9 47.6+17.6 0.71
Nominal ﬁnal balloon size (mm)
Main branch 3.15+0.35 3.17+0.33 0.78
Side branch 2.51+0.22 2.61+0.24 0.02
Maximal inﬂation pressure (atm)
Main branch 13.49+2.46 13,71+2.54 0.53
Side branch 12.33+3.28 12.95+2.30 0.14
Cross over (%) 19 (18.8) 3 (3.0) ,0.001
Final kissing (%) 101 (100) 101 (100) 1.0
Multi vessel PCI (%) 36 (35.6) 35 (34.7) 0.50
Contrast volume (mL) 204+86 203+109 0.94
Procedure time (min) 51+23 56+25 0.16
Fluoroscopy time (min) 13+71 5 +9 0.20
Patient radiation exposure
(Gy cm
2)
41.2+23.2 47.7+37.6 0.16
LAD, left anterior descending coronary artery; LCX, left circumﬂex coronary
artery; RCA, right coronary artery; PCI, percutaneous coronary intervention.
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Table 3 Quantitative coronary angiography according to bifurcation segments
Proximal segment Distal segment Side branch
Prov. Syst. P-value Prov. Syst. P-value Prov. Syst. P-value
In-stent MLD (mm)
Pre-PCI 1.53+0.86 1.63+0.86 0.42 1.28+0.71 1.20+0.67 0.43 1.13+0.62 1.11+0.64 0.80
Post-PCI 3.22+0.45 3.17+0.51 0.46 2.77+0.39 2.74+0.41 0.60 1.97+0.46 2.30+0.43 ,0.001
Follow-up 3.23+0.54 3.16+0.58 0.37 2.77+0.67 2.65+0.60 0.22 1.93+0.57 1.98+0.76 0.65
In-stent per cent diameter stenosis
Pre-PCI 50.3+26.7 47.3+26.1 0.42 53.4+24.4 54.9+24.3 0.64 53.1+23.5 54.4+22.3 0.68
Post-PCI 2.52+9.34 3.03+10.7 0.72 7.64+8.63 9.32+9.73 0.20 16.6+13.9 9.56+11.4 ,0.001
Follow-up 2.95+12.0 3.57+11.4 0.71 9.90+18.4 12.5+14.5 0.28 18.3+20.9 23.4+27.3 0.15
Acute gain (mm) 1.69+0.84 1.54+0.83 0.21 1.48+0.77 1.53+0.69 0.65 0.84+0.68 1.19+0.60 ,0.001
In-stent late loss (mm) 20.01+0.42 20.02+0.46 0.90 0.01+0.62 0.08+0.51 0.43 0.03+0.57 0.32+0.82 0.005
Edge MLD (mm)
Post-PCI 2.92+0.53 2.92+0.59 0.99 2.21+0.53 2.21+0.46 0.97 1.90+0.51 1.92+0.48 0.84
Follow-up 2.94+0.60 2.98+0.66 0.67 2.26+0.59 2.30+0.48 0.62 1.94+0.48 1.94+0.63 0.99
Edge per cent diameter stenosis
Post-PCI 8.37+8.37 9.65+9.04 0.30 14.9+10.5 14.6+9.36 0.83 15.1+12.4 16.3+10.5 0.44
Follow-up 9.70+10.1 8.47+10.7 0.41 13.9+10.4 13.4+8.19 0.70 12.5+11.1 13.2+11.9 0.65
Edge late loss (mm) 20.29+0.69 20.17+0.66 0.25 20.50+0.64 20.35+0.57 0.09 0.01+0.29 20.03+0.33 0.62
MLD, minimal luminal diameter.
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3Consistent with the data on per cent diameter stenosis, minimal
luminal diameters in the side branch at angiographic follow-up
did not differ signiﬁcantly between the two groups (Table 3).
Both acute gain and late loss in the side branch were signiﬁcantly
larger after routine T-stenting than after provisional T-stenting
(Table 3).
In the proximal and distal segments of the main branch, average
in-stent per cent diameter stenoses at follow-up ranged between 3
and 12%, and did not show any signiﬁcant differences between the
two study groups (P ¼ 0.28). Binary restenosis rate of the main
branch was 7.3% after provisional T-stenting and 3.1% after
routine T-stenting (RR 2.3; 95% CI 0.6–9.0; P ¼ 0.19). Similar to
the ﬁndings in the side branch, there was no detectable late loss
in any of the edges of the main branch.
The maximal per cent diameter stenosis involving the bifurcation
irrespective of the site of restenosis (side branch, proximal, or
distal main vessel) was 29.7+18.7% after provisional T-stenting
and 32.2+23.5% after routine T-stenting (mean difference
22.4%; 95% CI 28.5 to 3.6%; P ¼ 0.43; Figure 3), translating into
an overall binary angiographic restenosis rate of 12.5 and 13.5%,
respectively (RR 0.91; 95% CI 0.39–2.12; P ¼ 0.83). We did not
ﬁnd any signiﬁcant differences in the maximal per cent diameter
stenosis between the two groups, irrespective of whether only
the side branch or only the main branch or both branches were
involved (Figure 3).
Clinical outcome
Between the two study groups, there were no signiﬁcant differ-
ences in clinical outcome. During 1 year follow-up (Table 4),
target lesion intervention was performed in 10.9% of the patients
assigned to provisional T-stenting and 8.9% of the patients assigned
to routine T-stenting (RR 1.2; 95% CI 0.5–2.9; P ¼ 0.64). Likewise,
we did not ﬁnd a signiﬁcant difference in the rate of target lesion
re-intervention after routine T-stenting as compared with that
after provisional T-stenting, either for the side branch (7.9 vs.
Figure 3 Comparison of maximal per cent diameter stenosis
involving the bifurcation irrespective of the site of restenosis
(side branch, proximal, or distal main vessel) between the two
study groups, before intervention and at 9 month follow-up for
the entire cohort and for strata deﬁned by side branch or main
branch involvement at 9 month follow-up. The corresponding
Medina classiﬁcations are given below the graph. Columns rep-
resent mean and error bars represent standard deviation.
................................................................................
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Table 4 One year clinical outcome
Provisional
T-stenting
(n 5 101)
Routine
T-stenting
(n 5 101)
P-value
Death (%) 2 (2.0) 1 (1.0) 1.0
Non-fatal myocardial
infarction (%)
1 (1.0) 2 (2.0) 1.0
Death or non-fatal
myocardial
infarction (%)
3 (3.0) 3 (3.0) 1.0
Target lesion
revascularization
(%)
11 (10.9) 9 (8.9) 0.64
Main branch 7 (6.9) 3 (3.0) 0.19
Side branch 5 (5.0) 8 (7.9) 0.39
Any MACE (%) 13 (12.9) 12 (11.9) 0.83
Stent thrombosis by ARC deﬁnition (%)
Deﬁnite 1 (1.0) 2 (2.0) 1.0
Probable 1 (1.0) 0 (0) 1.0
Possible 1 (1.0) 1 (1.0) 1.0
ARC, Academic Research Consortium; MACE, major adverse cardiac event.
Figure 2 Cumulative frequency of per cent diameter stenosis
of the side branch at 9 month angiographic follow-up in patients
assigned to routine T-stenting (red) or to provisional T-stenting
(green). The broken lines indicate the percentage of lesions
with (above the line) and without (below the line) restenosis
(per cent diameter stenois  50%). P-value by two-tailed t-test.
M. Ferenc et al. 28645.0%; RR 1.6; 95% CI 0.5–4.9; P ¼ 0.39) or for the main branch
(3.0 vs. 6.9%; RR 0.4; 95% CI 0.1–1.7; P ¼ 0.19).
During 1 year follow-up, one patient assigned to routine T-
stenting and two patients assigned to provisional T-stenting died.
Causes of death were sudden death at Day 48 in the patient with
side-branch stent and in the patients without side-branch stents,
pump failure at Day 5, and septic shock at Day 39. In addition,
there were two non-fatal myocardial infarctions in the routine
T-stenting group at Days 4 and 15 and one in the provisional
T-stenting group at Day 3, all in the area supplied by the bifurcation
treated. In both groups, three patients met the ARC criteria
for deﬁnite, probable, or possible stent thrombosis during 1 year
follow-up. The composite incidence of death and myocardial infarc-
tion as well as the composite incidence of death and myocardial
infarction and TLR did not differ signiﬁcantly between the two
study groups (Table 4). Extending follow-up to 2 years (Figure 4),
we observed one additional death in the routine T-stenting group
(witnessed sudden death with documented open stents) and two
in the provisional T-stenting group (carcinoma of pancreas, cerebro-
vascular accident). There were no further non-fatal myocardial
infarctions, but one additional TLR in each group.
Discussion
Our randomized study on treatment of coronary bifurcation
lesions with SES compared the angiographic outcome of routine
T-stenting with that of provisional T-stenting. As our key result
we did not ﬁnd that routine T-stenting reduced the risk of the side-
branch restenosis. At 9 month angiographic follow-up, none of the
angiographic variables for restenosis of the side branch, including
in-segment per cent diameter stenosis, our primary endpoint,
showed a signiﬁcant difference between the two treatment arms.
We even found a trend towards a higher risk of restenosis with
routine T-stenting. Consistent with the angiographic ﬁndings, the
need for re-intervention at the side branch was similar in both
treatment arms and ranged ,8%. Contrary to the ﬁrst randomized
trial on SES for coronary bifurcation lesions,
5 our ﬁndings do not
raise any speciﬁc safety concerns. Irrespective of the treatment
assigned, the 1 year incidences of death and myocardial infarction
and of stent thrombosis by any of the ARC criteria were in the
range of 3%, with very few additional cardiac events between 1
and 2 years. The clinical outcome, thus, was quite comparable
with that encountered with on-label use of drug-eluting stents.
Consistent with all previous studies, we found a lower angiographic
and clinical restenosis in the main branch as compared with the
side branch with no signiﬁcant effect of side-branch treatment
on main-branch outcome.
The outcome in the side branch was the result of two opposing
effects: compared with the respective alternative treatment strat-
egy, acute gain was signiﬁcantly better with routine T-stenting,
but late loss was signiﬁcantly lower with provisional T-stenting.
Previous studies showed that the mechanisms of restenosis differ
substantially between plain balloon angioplasty and stent place-
ment. After stent placement, neointima formation accounts for
.90% of the lumen loss, whereas after plain balloon angioplasty
the contribution of neointima formation to restenosis is
,30%.
11–13 With plain balloon angioplasty, remodelling due to
elastic recoil and late vessel shrinkage is the predominant mechan-
ism of post-procedural lumen loss.
11,12 It may be speculated that
the stent in the main branch, which is partially pushed into the
oriﬁce of the side branch by the kissing balloon manoeuvre,
limited remodelling of the side branch. This may explain the extra-
ordinarily low late loss in the side branch after plain balloon angio-
plasty, which was smaller than anything reported before for plain
balloon angioplasty. Hence, the ﬁnal kissing balloon manoeuvre
that was performed even in all patients assigned to provisional T-
stenting appears to be an important feature of our study.
While our study was under way, the results of NORDIC Bifur-
cation Study, another randomized study on coronary bifurcation
lesions, became available.
14 NORDIC included 413 patients ran-
domly assigned to stenting both the main vessel and the side
branch or stenting the main vessel only, with optional stenting of
the side branch.
14 NORDIC used the same stent type as our
study, but applied a variety of procedural techniques. Consistent
with our ﬁndings and those of an earlier smaller trial,
15
NORDIC did not detect any signiﬁcant difference between the
two study arms in its primary endpoint, major adverse cardiac
events (MACE). The authors cautioned, however, that the study
was considerably underpowered given the low MACE rate
found.
15 Overall, MACE rates in NORDIC were lower than
those in our study. This may be explained by differences in risk
proﬁle of the study cohorts.
NORDIC also reported angiographic follow-up data for 307
patients.
14 Per cent diameter stenosis of the side branch at
follow-up was signiﬁcantly lower in the group assigned to
routine stenting of the side branch as compared with the group
assigned to optional side-branch stenting only. Thus, considering
the primary endpoint of our study, NORDIC was positive in
favour of routine side-branch stenting.
14 When comparing the
angiographic results of NORDIC to our study, it is conspicuous
that the strategy with routine stenting of the side branch yielded
a similar outcome at follow-up with respect to in-stent per cent
Figure 4 Kaplan–Meier estimates for freedom from death or
myocardial infarction and for freedom from target lesion revascu-
larization in patients assigned to routine T-stenting (red) or to
provisional T-stenting (green). P-values by log-rank test.
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and binary restenosis rate (11.5% in NORDIC vs. 12.5% in BBK)
of the side branch. Another observation that the two studies
have in common is the substantial late-loss in the side branch
with routine side-branch stenting (0.20+0.57 mm in NORDIC
vs. 0.32+0.82 mm in BBK) and the negligible late-loss with provi-
sional side-branch stenting (20.04+0.52 mm in NORDIC vs.
0.03+0.57 mm in BBK). Nevertheless, the 9 month outcome in
the side branch of the group with provisional side-branch stenting
in BBK was considerably better than the corresponding group in
NORDIC as evidenced by in-stent per cent diameter stenosis
(18.3+20.9 vs. 31+22%) and binary restenosis rate (9.4 vs.
19.2%) of the side branch. Given the similar side-branch late
loss, the favourable outcome of the side branch in the group
with provisional T-stenting in BBK must have been caused by a
better acute gain as compared with NORDIC. We attribute this
difference to the ﬁnal kissing-balloon dilatation that was performed
in all patients of the provisional T-stenting group in BBK, but only
in 32% of the optional side-branch stent group in NORDIC.
Hence, the intention to avoid the side-branch stent should not
prevent meticulous optimization of the side-branch results by
kissing-balloon inﬂations with adequately sized balloons.
The issue of nomenclature needs to be addressed. Dealing with
two variations of the T-stenting technique with stenting of the
main branch ﬁrst, we addressed the question whether with this
general approach a stent should be placed in every side branch
or only in side branches with an inadequate primary result. This
counterpart is best described by the antonyms ‘systematic’ vs. ‘pro-
visional’. A recent review manuscript,
7 however, which categorized
more than 20 subclasses bifurcation stenting, named a T-stenting
technique that places the side-branch stent ﬁrst ‘systematic T-
stenting’ whereas the technique that places the side branch after
the main branch stent was named ‘elective T-stenting’. We felt
that the term ‘elective’ is misleading in the context of our study
as it is generally understood as the antonym to ‘emergent’. To
avoid confusion, we, therefore, used the terms ‘routine T-stenting’
and ‘provisional T-stenting’.
Limitations
We designed our trial as a mechanistic angiographic study that
addressed the issue of side-branch stenting as potential means of
reducing side-branch restenosis after treatment of coronary bifur-
cation lesions with SES. Hence, our study was not powered to
address clinical endpoints. A recent survey of the published litera-
ture identiﬁed per cent diameter stenosis, our primary outcome
measure, as a valid surrogate for TLR.
16 Given that the point esti-
mate for per cent diameter stenosis at 9 months even favoured
provisional stenting, our observation that routine T-stenting did
not reduce the incidence of clinically relevant recurrences after
treatment of coronary bifurcation lesions appears to be robust.
We need to consider the potential bias because our study could
not be blinded. To avoid such bias in the assessment of our
primary endpoint and other angiographic variables, we used a com-
puterized quantitative analysis system with only minimal operator
interference.
The per cent diameter stenosis in the side branch after provi-
sional T-stenting was lower than projected, which reduces the
power to detect the projected 33% reduction in per cent diameter
stenosis by routine T-stenting. On the other hand, angiographic
follow-up was substantially higher than anticipated, 96 instead of
80 patients in each group. Thus, with the observed mean per
cent diameter stenosis of 25.4% in the entire cohort and a
common standard deviation of 22.5%, we maintain an 84%
power to detect a 33% relative difference in per cent diameter ste-
nosis in the side branch between the two groups at a level of sig-
niﬁcance of 5%.
Clinical implications
Irrespective of the proportion of patients receiving a side-branch
stent, our T-stenting approach to the treatment of coronary bifur-
cation lesions with SES resulted in a favourable 2 year clinical
outcome with a need for re-intervention in 11% of our patients.
Our ﬁndings do not suggest placing a stent in a side branch that
achieved an acceptable primary angiographic result after ﬁnal
kissing-balloon dilatation. On the other hand, placement of a side-
branch stent for inadequate results such as relevant residual steno-
sis or extensive dissection does not appear to deteriorate late
outcome. Thus, the intention to avoid a side-branch stent should
not prevent meticulous optimization of the side-branch result,
including a ﬁnal kissing balloon manoeuvre.
The observed 2 year incidence of deﬁnite and probable stent
thrombosis of 2% does not raise any speciﬁc concerns with
respect to the treatment of coronary bifurcation lesions with
SES, but clearly needs to be improved. Recent advances in the
concomitant antiplatelet therapy, such as the development of
more potent P2Y12-receptor antagonists,
17,18 hold promise in
this respect.
After placement of an SES, late loss in the side branch is still
substantially higher than that in the main branch. Hence, there is
room for further optimization of stent design with regard to the
need of side branches.
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